Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Beijing Wantai Biological
ISIN CNE100004090
|WKN A2QK68
Market cap (in EUR)
4,769 m
Country
China
Sector
Healthcare
Dividend yield
0.70%
Overview
Description
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices China
Financials
Key metrics
| Market capitalisation, EUR | 4,769 m |
| EPS, EUR | -0.04 |
| P/B ratio | 3.2 |
| P/E ratio | 780.4 |
| Dividend yield | 0.70% |
Income statement (2025)
| Revenue, EUR | 223 m |
| Net income, EUR | -49 m |
| Profit margin | -21.98% |
What ETF is Beijing Wantai Biological in?
There are 84 ETFs which contain Beijing Wantai Biological. All of these ETFs are listed in the table below. The ETF with the largest weighting of Beijing Wantai Biological is the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99 € | 4500 | View offer** | |
 | 0.95 € | 3100 | View offer* | |
 | 0.00 € | 8045 | View offer* | |
 | 1.00 € | 2500 | View offer* | |
 | 0.00 € | 7560 | View offer* |
Source: justETF Research; as of 6/2026. The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.